{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-415560","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2026-10-06T20:07:53+00:00","discovered_at":"2026-10-06T20:09:00.314728+00:00","generated_at":"2026-10-12T16:20:19.589924+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bolt Biotherapeutics Amends Redwood City Lease, Pays $1.0M and Accelerates Expiration","bullets":["Bolt Biotherapeutics entered a Second Amendment to its Chesapeake Master Lease with landlord HCP LS Redwood City LLC on October 1, 2026.","The company paid $1.0 million and acknowledged HCP LS Redwood City LLC can draw the existing $1.5 million letter of credit in its entirety.","Lease expiration is accelerated to December 31, 2027, or earlier after closing a financing or other Corporate Transaction.","A Corporate Transaction closing would trigger an additional $4.5 million termination payment to the landlord.","Bolt will remit 100% of sublease rent and common area maintenance payments from 800 Building subtenants to the landlord."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-415560","json":"https://secwatch.observer/filing/0001193125-26-415560.json","markdown":"https://secwatch.observer/filing/0001193125-26-415560.md","text":"https://secwatch.observer/filing/0001193125-26-415560.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526415560/0001193125-26-415560-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526415560/bolt-20261001.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:20:19.589924+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}